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ABSTRACT  
Quality is the most important issue in the pharmaceutical field due to the presence of a drug which is considered as safe and therapeutically 
active agent. In-vitro evaluation ensures their quality, bioavailability as well as optimum therapeutic activity. Paracetamol (acetaminophen) 
which are the active metabolites of phenacetin is commonly used for the relief of headaches and pains, and is a major ingredient in numerous 
cold and flu remedies. Paracetamols are available in different brands in Indian market. The main objective of the present study was to conduct 
the comparative in-vitro dissolution studies of various brands collected from the local market to determine whether all the formulations used 
were equivalent or significantly different. The calibration curve was constructed covering the concentration range of 1 to 10 mcg/ml at 268 nm 
by UV spectrophotometer (UV 2203 Double beam spectrophotometer, Shimadzu).  Five different brands of Paracetamol of 500 mg conventional 
tablets from different manufacturers were selected in the study and dissolution testing in Phosphate buffer at pH 7.4 was conducted from each 
brands for 90 mins by using dissolution testing apparatus USP type-II. The dissolution rate was subjected to various mathematical models like 
zero order, first order, Higuchi and Hixson-Crowell equations to elucidate the kinetic behavior of drug release from the test samples. Different 
release kinetics model of all the selected brands was assuring the quality standard of manufacturing.  
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INTRODUCTION: 
Oral dosage form like tablets, capsules, suspensions etc is 
one of the most common method used for the administration 
of drug.. Among all, tablets are more widely used being 
tempered free, cost effective, and stable. In formulation 
systems, manufacturing process and raw materials used 
affects the quality of finished product. It is very much 
essential to determine the parameters of tablets to ensure 
the quality of the product. Quality of the finished product 
depends upon the early developmental process. A tablet 
contains a drug molecule and excipients which are used 
mainly to maintain the physical parameters as well as to 
control the release of drug from its dosage from. For a single 
generic drug, various brands are available. Quality of all 
available brands needs to be assessed in order to provide an 
efficacious formulation, this responsibility increases in case 
of over the counter (OTC) medicines, quality of the product 
vary from manufacturer to manufacturer [1]. 
Paracetamol, a widely prescribed Non-steroidal anti-
inflammatory drug (NSAID) is used for the relief of pains 
associated with many parts of the body. Chemically, it is 4-
hydroxy acetanilide (acetaminophen) which belongs to the 
non-salicylate analgesic group. This drug which has well-
established metabolic and pharmacokinetic (pK) profiles is a 
universally accepted analgesic and antipyretic drug. It is 
poorly aqueous soluble and its frequency of administration is 
high due to low bioavailability [2,3]. 
Paracetamol has analgesic properties comparable to those of 
aspirin, while its anti-inflammatory effects are weaker. It is 
better tolerated than aspirin in patients in whom excessive 
gastric acid secretion or prolongation of bleeding time may 
be a concern. Available without a prescription, it has in 
recent years increasingly become a common household 
drug.[4] 
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Fig. 1: Structure of Paracetamol [4] 
Dissolution test, a qualitative and quantitative tool is one of 
the in vitro tests help to operate the quality of oral 
pharmaceutical solid dosage forms such as tablets and 
capsules. This test gives some important information about 
the biological availability of a drug and also batch to batch 
consistency of products [5].  
The quality of marketed drugs determines the conditions of 
the patients treated. On the other hand, health condition of a 
consumer can be put at risk by the use of substandard drugs. 
So, continuous segregating process should be needed by the 
consumer organization for the awareness about the quality 
of drug available. Specially, some small and medium 
pharmaceutical industries do not analyse their drug or 
product properly before marketing due to the high expense 
for maintaining the quality control [6]. 
Therefore, it was decided to carry out the comparative 
evaluation of in vitro dissolution qualities of various 
commercially available paracetamol tablet samples. 
Paracetamol tablets of 500 mg were chosen for the study. 
Statistical assessment of various in vitro dissolution 
parameters was conducted to establish if there were any 
significant differences among them. 
MATERIALS AND METHOD: 
Materials:- Paracetamol tablets (500 mg) were collected 
from the local market in west Bengal from the different 
company which is given in Table 1. All other ingredients 
were taken as an analytical grade. 
 
Table 1: List of collected marketed paracetamol tablet 
Sl. No. Brand Name Company Name Manufacturing 
date 
Expiry date  Batch code 
1.  Apex 500 Apex Lab. Pvt Ltd 24.01.2019 28.11.2021 F - A 
2.  Crocin 500 Remidex Pharma Pvt 
Ltd 
17.02.2019 21.12.2021 F - B 
3.  Calpol 500 GlaxoSmithKline  10.08.2019 21.11.2021 F - C 
4.  Pyrigesic 500 East India Pharma 18.08.2019 19.11.2021 F - D 
5.  Arden 500 Adonis Lab. Pvt. Ltd. 14.05.2019 16.12.2021 F - E 
 
 
Methodology:  
Preparation of Phosphate buffer at pH 7.4 [7]: 
Dissolve 27.218g of potassium di-hydrogen phosphate and 
7.99g of sodium hydroxide in sufficient distilled water 
containing in the 1000ml volumetric flask and to make up to 
the volume 1000ml. 
Place 50ml of 0.2 M Potassium di-hydrogen phosphate in a 
200ml volumetric flask, add the specified volume of 0.2 M 
sodium hydroxide and then add distilled water to make up 
the volume 200ml. 
Preparation of calibration curve of paracetamol [8]:   
Stock solution of drug (1mg/ml) is prepared by dissolving 
100 mg of drug in 100 ml solution of phosphate buffer pH 
7.4 in 100 ml volumetric flask (to get 1000 µg/ml drug 
solutions) with vigorous shaking.  A aliquot sample (10 ml) 
from previous stock is diluted to 100 ml with phosphate 
buffer pH 7.4 to get a stock solution to get a concentration of 
100 µg/ml of drug. The stock solution was filtered through 
Whatmann filter paper No.41. The respective samples at the 
range of .1 ml to 1ml was taken in each test tube separately 
and diluted with phosphate buffer pH 7.4 to make the total 
volume upto 10 ml to make a concentration range 1 to 10 
mcg/ml. The standard solutions for the drug having 
concentration 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10 µg/ml was 
prepared with phosphate buffer pH 7.4 from the stock 
solution. A calibration curve was plotted between 
absorbance v/s concentration to get the linearity and 
regression equation. 
In vitro dissolution study [8]:  
Dissolution rate studies were performed in 900 ml of 
phosphate buffer at ph 7.4 at 37 ± 0.5 0C, using 6-station USP 
type-II (paddle) apparatus with paddle rotating at 50 rpm. 
Different marketed 500 mg of Paracetamol tablet was placed 
in dissolution basket. At fixed time intervals, samples 
withdrawn were filtered and spectrophotometrically 
analysed for the drug content at 268 nm. The rate of drug 
release at different time interval was calculated and the 
kinetics of drug release was analysed according the different 
kinetics models like zero order, first order, higuchi model 
etc.  
RESULT AND DISCUSSION: 
A UV absorption maximum was determined by scanning 
10µg/ml solution of paracetamol in phosphate buffer 7.4, in 
between 200-400 nm by using UV-visible 
spectrophotometer. Further a representative spectrum was 
drawn of paracetamol in phosphate buffer pH 7.4. The 
absorbance of solutions of pure paracetamol drug were 
measured at 268 λ max shown in table 2 and a calibration 
curve was plotted with the regression value 0.999 shown in 
Fig. 2. The obtained regression value was indicating about 
the linearity between the concentration (Conc.) and 
absorbance (Abs.) 
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Table 2: Absorption profile of paracetamol 
Conc. (mcg/ml) Abs. 
1 0.06 
2 0.108 
3 0.164 
4 0.219 
5 0.285 
6 0.33 
7 0.39 
8 0.455 
9 0.510 
10 0.555 
 
 
Fig. 2 : Calibration curve of paracetamol using 
phosphate buffer at 7.4 
In-Vitro release study: 
The in vitro dissolution studies of the marketed paracetamol 
tablets was carried out using USP type II apparatus 
(Electrolab, Mumbai, India) at 50rpm. The dissolution 
medium consisted of 900 ml of distilled water maintained at 
37 ± 0.5°C. The drug release at different time intervals was 
measured using an UV visible spectrophotometer.  
The dissolution rate was subjected to various mathematical 
models like zero order given in Table 3, first order given in 
Table 4, Higuchi model given in Table 5 and Krosmeyer 
Peppas model given in Table 6 and to elucidate the kinetics 
behaviour and mechanism of drug release from the different 
marketed tablets, data obtained from the release studies 
were fitted to various models shown in Fig. 3 to Fig. 6.   The 
comparative evaluation of in vitro dissolution qualities of 
various paracetamol tablets was done by contrasting the 
values of regression coefficient given in table 7. After 
evaluating all of the data, it has been concluded that among 
all of the formulation, apart from F – A and F – E batch, all 
other batches was showing better regression coefficient. It 
was observed from the regression coefficient values that the 
release kinetics of' paracetamol from all the tablets appears 
to be almost uniform. 
  
Table 3: Drug release data fitted to Zero order model 
 Cumulative % drug release 
Time (min) F - A F – B F – C F – D F - E 
5 41.98 16.51 9.9 37.32 39.63 
10 42.644 25.451 29.391 41.944 40.624 
20 46.615 28.072 34.353 44.594 41.944 
30 49.584 32.033 36.003 49.214 46.574 
45 54.544 32.033 36.334 53.175 48.554 
60 61.815 43.603 37.984 58.135 50.865 
75 65.126 43.934 39.964 61.206 55.165 
90 69.096 47.864 40.154 63.746 58.796 
 
 
Fig. 3: Comparative zero order kinetics of different marketed paracetamol tablet 
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Table 4: Drug release data fitted to First order model 
Log cumulative % of drug retained 
Time (min) F - A F – B F – C F – D F - E 
5 1.763 1.921 1.958 1.797 1.78 
10 1.758 1.872 1.848 1.763 1.773 
20 1.727 1.856 1.817 1.743 1.763 
30 1.702 1.832 1.806 1.705 1.727 
45 1.657 1.832 1.803 1.67 1.711 
60 1.581 1.751 1.792 1.621 1.691 
75 1.542 1.748 1.778 1.588 1.651 
90 1.49 1.717 1.777 1.559 1.614 
 
 
 
Fig. 4: Comparative First order kinetics of different marketed paracetamol tablet 
 
Table 5: Drug release data fitted to Higuchi model 
Cumulative % of drug release 
Square root of time F - A F – B F – C F – D F - E 
2.236 41.98 16.51 9.9 37.32 39.63 
3.162 42.644 25.451 29.391 41.944 40.624 
4.472 46.615 28.072 34.353 44.594 41.944 
5.477 49.584 32.033 36.003 49.214 46.574 
6.708 54.544 32.033 36.334 53.175 48.554 
7.745 61.815 43.603 37.984 58.135 50.865 
8.66 65.126 43.934 39.964 61.206 55.165 
9.486 69.096 47.864 40.154 63.746 58.796 
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Fig. 5: Comparative Higuchi kinetics of different marketed paracetamol tablet 
Table 6: Drug release data fitted to Krosmeyer peppas model 
Log cumulative % of drug release 
Log time (min) F - A F – B F – C F – D F - E 
0.698 1.623 1.217 0.99 1.571 1.598 
1 1.629 1.405 1.468 1.622 1.608 
1.301 1.668 1.448 1.535 1.649 1.622 
1.477 1.695 1.505 1.556 1.692 1.668 
1.653 1.736 1.505 1.56 1.725 1.686 
1.778 1.791 1.639 1.579 1.764 1.706 
1.875 1.813 1.642 1.601 1.786 1.741 
1.954 1.839 1.68 1.603 1.804 1.769 
 
 
Fig. 6: Comparative Krosmeyer peppas kinetics of different marketed paracetamol tablet 
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Table 7: Comparison of regression coefficient of different kinetics model 
Batch Code Zero order First order Higuchi model Krosmeyer peppas 
model 
F - A 0.972 0..573 0.969 0.903 
F – B 0.993 0.938 0.995 0.975 
F – C 0.988 0.994 0.960 0.892 
F – D 0.920 0.989 0.945 0.994 
F - E 0.532 0.991 0.664 0.692 
 
CONCLUSION: 
Bioavailability and absorption of drug is dependent on 
dissolution profile. A dissolution study gives an idea about 
the amount of drug available for absorption after oral 
administration.  In the present study, the release of 
paracetamol from all tablets, specially F – C batch (Crocin 
500) was followed sustained release; though the drug 
release in 60 mints were almost about 60% which meets BP 
Specifications. 
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